Back to ABIVAXInsider 
Company
TRUFFLE CAPITAL SAS — ABIVAX
Filing 2023DD942355Published 14 Dec 2023France public disclosures
InitialEffective
Summary
TRUFFLE CAPITAL SAS
Philippe Pouletty, Membre du conseil d'administration
ABIVAX
Last 12 months
- Transactions
- Not available
- Total reported value
- Not available
CompanyABIVAX
ISINFR0012333284
Last 12 months
- Transactions
- Not available
- Total reported value
- Not available
Reported buys
€0.00
Reported sales
€19,382.80
Net buy/sell
-€19,382.80
Other reported value
€0.00
Gross reported value
€19,382.80
Transactions
1
Transactions
| Execution date | Direction | Nature | Instrument | Settlement | Quantity | Unit price | Total | Venue |
|---|---|---|---|---|---|---|---|---|
| 10 Dec 2023 | SellCession / SELL | DISPOSAL | SHARE | UNKNOWN | 2,062 | €9.40 | €19,382.80 | XPAR |
Sell
Execution date10 Dec 2023Cession / SELL
DISPOSAL · SHARE · UNKNOWN · XPAR
- Quantity
- 2,062
- Unit price
- €9.40
- Total
- €19,382.80
Evidence
- AMF · France2023DD942355
Corrections
Identify the affected field and a source that supports the correction. Use the private contact for rights requests; do not attach identity documents unless necessary and requested.